The following are the M&A deals, rumors and chatter circulating on Wall Street for Monday May 13, 2013:
AsiaInfo-Linkage to be Acquired by Group Led by CITIC Capital Partners for $12.00/Share in CashThe Deal:
AsiaInfo-Linkage
ASIA and CITIC Capital Partners announced today a merger agreement under which AsiaInfo-Linkage will be acquired by a private investor consortium led by CITIC Capital Partners. Under the terms of the merger agreement AsiaInfo-Linkage shareholders will receive $12.00 in cash for each share of common stock they hold. The deal is valued at approximately 890 million and is subject to shareholder and regulatory approval.
AsiaInfo-Linkage closed at $11.60 Monday, a loss of $0.08 on 12 times average volume.
Report Qihoo 360 to Acquire Sohu's Sogou for $1.4B:
Shares of Chinese Internet company Sohu.com
SOHU rose sharply in early trading Monday on a report from
WantChinaTimes that it was selling search engine company, Sogou, to Qihoo 360 Technology
QIHU for $1.4 billion.
Spokespersons for the companies were not available for comment.
Sohu.com gained 4% Monday, closing at $63.20, while Qihoo 360 lost 4%, closing at $38.53.
Report Microsoft Purchase of Nook Digital Assets from Barnes & Noble Not HappeningThe Rumor:
Shares of Barnes & Noble
BKS sold off sharply Monday, on a report from
Insider Monkey that "nothing imminent" was happening with regard to a Microsoft
MSFT purchase of the digital assets of Nook Media, according to a source. On May 9,
TechCrunch reported that Microsoft was preparing a $1 billion bid for the Nook assets.
Spokespersons for Barnes & Noble and Microsoft declined comment on the rumor.
Barnes & Noble closed at $21.10 Monday, a loss of 9.5% on 5.5 times average volume.
Report AstraZeneca, Cubist, Bidding for Optimer PharmaceuticalsThe Rumor:
Shares of Optimer Pharmaceuticals
OPTR surged higher just before the market close Monday on a report from
Bloomberg that AstraZeneca
AZN and Cubist Pharmaceuticals
CBST, were among companies that have submitted bids for Optimer Pharmaceuticals
OPTR, according to sources.
Spokespersons for the companies were not immediately available for comment.
Optimer Pharmaceuticals closed at $14.66 Monday, a gain of 14% on 4 times average volume.
Loading...
Loading...
ASIAMatthews International Funds Matthews Pacific Tiger Active ETF
$27.890.36%
Edge Rankings
Momentum
Not Available
Price Trend
Short
Medium
Long
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in